%0 Journal Article
%T Letter to the Journal Office: Comment on 'J. Cancer Mol. 3(6): 175-181, 2008'
%A William Cho
%J Journal of Cancer Molecules
%D 2008
%I 
%X Dear Prof. He, I have read your recent paper entitled, "Serum Levels of Apolipoprotein A-II as a Potential Marker for Cholangiocarcinoma", published in Journal of Cancer Molecules. Congratulations on your work and thank you for citing a paper (ref. 32) from my group. However, I would like to address that it is better to refer to other papers of my group for a relevancy as the paper you cited (Ref. 32) is on SARS only. Thank you for your kind attention. Discussion: SELDI-TOF-MS has been successfully applied in early biomarker detection and identification in multiple adult cancers, including ovarian, prostate, lung, and breast cancers [27-35]. 32. Yip T, Chan J, Cho W, Yip T, Wang Z, Kwan TL, Law SCK, Tsang DNC, Chan JKC, Lee KC. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid A protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 51: 47-55, 2005. The appropriate papers should be cited instead: Cho WC, Yip TT, Ngan RK, Yip TT, Podust VN, Yip C, Yiu HH, Yip V, Cheng WW, Ma VW, Law SC. ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin Chem 53: 241-250, 2007. Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res 10: 43-52, 2004. Best regards,William Cho, Ph. D., Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, The People's Republic of China
%U http://www.mupnet.com/JOCM%204(1)%2029.pdf